InvestorsHub Logo
Followers 827
Posts 119499
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 406

Wednesday, 07/31/2019 10:34:46 AM

Wednesday, July 31, 2019 10:34:46 AM

Post# of 866
FDA approves Keytruda monotherapy in second-line esophageal cancer for PD-L1-positive patients:

https://finance.yahoo.com/news/fda-approves-monotherapy-indication-merck-104500838.html

This approval is based on the KEYNOTE-181 and KEYNOTE-180 studies (the latter included only third-line patients).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News